FEFRX | VIVAX | FEFRX / VIVAX | |
Total Expense Ratio | 0.65 | 0.17 | 382% |
Annual Report Gross Expense Ratio | 0.73 | 0.17 | 429% |
Fund Existence | 9 years | 33 years | - |
Gain YTD | 21.110 | 9.738 | 217% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 453M | 208B | 0% |
Annual Yield % from dividends | 1.11 | 1.97 | 56% |
Returns for 1 year | 11.16 | 4.63 | 241% |
Returns for 3 years | 61.82 | 42.99 | 144% |
Returns for 5 years | 20.83 | 71.78 | 29% |
Returns for 10 years | N/A | 129.45 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JANW | 36.15 | 0.10 | +0.28% |
AllianzIM US Large Cap Buffer20 Jan ETF | |||
HAPY | 24.53 | N/A | N/A |
Harbor Human Capital Factor Unconstrained ETF | |||
EMOT | 23.83 | N/A | N/A |
First Trust S&P 500 Economic Moat ETF | |||
NPFI | 26.39 | N/A | -0.02% |
Nuveen Preferred and Income ETF | |||
ARKG | 31.00 | -1.08 | -3.37% |
ARK Genomic Revolution ETF |